Pharma

The deployment has started with more than a dozen facilities across D-H's telehealth service area in New England with other markets coming in the future.

The sensor-laden device with a novel electronic dose counter is currently available for licensing and is expected to enter clinical studies later this year.

Located north of Toronto in Markham, LEO Innovation Lab will develop non-pharmaceutical solutions to treat psoriasis, which affects around 125 million people.

The stealthy startup is developing a tool that helps biomedical investigators accelerate the preclinical drug discovery and development pipeline.

CRV led the round, with participation from Accel Partners, Atlas Venture, Menlo Ventures and Sherpa Ventures; the money will be used to fuel growth.

The company will use the proceeds to support future growth to include new offerings, and a planned market entry and expansion into the U.S.

Pharmaceutical CIOs view analytics as the top driver of integration (52%), but pharmaceutical CMOs rank analytics near the bottom (cited by just 13%).

The data will be available to researchers via PhysioNet before the end of the year, offering web access to large collections of physiologic signals.

The healthcare startup is interested in accelerating medical advancement by bringing 21st century technology into living systems research.

Available as a free download, the application promises improved patient access and convenience in obtaining prescribed medications.